Physician profile
Stephen Leschak
NPI 1760430029
$42,415.76
in general payments reported to CMS, 2019-2025
25 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $673 · 2021: $7,163 · 2022: $17K · 2023: $13K · 2024: $3,177 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $12K · Food and Beverage: $4,503 · Travel and Lodging: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $11,916.67 |
| Food and Beverage | $4,503.31 |
| Travel and Lodging | $1,093.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $34,577.69 | 2021-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $5,496.98 | 2020-2025 | Ekosonic, Eluvia, General - Vascular Intervention |
| Philips North America LLC | $545.99 | 2020-2025 | (Az7) Lasers, (Br5) Peripheral Ivus, (P84) Igt Devices Systems |
| Medtronic, INC. | $407.77 | 2022-2025 | Hawkone, Interstim, Venaseal |
| Janssen Pharmaceuticals, INC | $218.97 | 2020-2022 | |
| Triad Life Sciences INC. | $140.23 | 2021 | |
| Balt USA, LLC | $137.93 | 2023 | Prestige Coil System |
| Penumbra, INC. | $125.82 | 2025 | Penumbra System |
| Asahi Intecc USA, INC. | $117.30 | 2021-2022 | |
| Ekos Corporation | $100.16 | 2019 | |
| Vasorum USA INC. | $85.59 | 2022-2023 | Celt Acd |
| Sirtex Medical INC | $85.14 | 2020 | |
| Averitas Pharma INC. | $66.63 | 2025 | Qutenza |
| Smith+Nephew, INC. | $58.87 | 2021-2025 | Collagenase Santyl |
| Reprise Biomedical, INC. | $48.41 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $42.08 | 2021-2022 | |
| Cms Imaging, INC. | $30.13 | 2024 | |
| Organogenesis INC. | $26.26 | 2022 | |
| Cardinal Health 200 LLC | $17.31 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.03 | 2022 | |
| Avinger INC. | $15.32 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.58 | 2025 | Nuzyra |
| Tactile Systems Technology INC | $14.39 | 2022 | |
| Abbott Laboratories | $14.30 | 2021 | |
| Medtronic Vascular, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Leschak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.